American pharmaceutical company
Issues related to Part D Medicare, the drug industry, and foreign aid maternal and child health; issues related to low income subsidy for Medicare Issues related to comparative effectiveness, issues related to the Independent Payment Advisory Board. Issues relating to trade negotiations; PNTR with Russia. Issues related to international tax, check the box, and tax deferral; issues related to the R&D tax credit and corporate tax reform. Issues related to vaccines, PCORI, ASP+6 and 340B; issues related to the Prescription Drug User Fee Act. Issues related to pharmaceutical drug safety track and trace program legislation.
BUD - Budget/Appropriations MMM - Medicare/Medicaid TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code HCR - Health Issues PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
JEFFREY FORBES ELIZABETH GREER ZACHARY WILLIAMS WESLEY RYAN WELCH JEFFREY FORBES ELIZABETH GREER ZACHARY WILLIAMS WESLEY RYAN WELCH JEFFREY FORBES ELIZABETH GREER ZACHARY WILLIAMS WESLEY RYAN WELCH JEFFREY FORBES ELIZABETH GREER ZACHARY WILLIAMS WESLEY RYAN WELCH JEFFREY FORBES ELIZABETH GREER ZACHARY WILLIAMS WESLEY RYAN WELCH JEFFREY FORBES ELIZABETH GREER ZACHARY WILLIAMS WESLEY RYAN WELCH